Core IM | Internal Medicine Podcast cover image

#192 Debate on First-Line Medications for Diabetes

Core IM | Internal Medicine Podcast

00:00

SGLT2s as a Low-Interference Option for Busy Patients

Keri argues SGLT2s provide modest weight, blood pressure, and A1c benefits with minimal GI side effects for working patients.

Play episode from 13:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app